Target amount for reasonable incomplete revascularization

Original title: Reasonable incomplete revascularisation after percutaneouscoronary intervention: the SYNTAX Revascularisation Index. Reference: Philippe Généreux et al. EuroIntervention 2014;10-online publish-ahead-of-print.

While the absolute amount of residual disease after coronary angioplasty is associated with poor prognosis, the proportion of treated coronary disease modifying the prognosis is still to be determined. This study attempted to quantify the proportion of coronary disease treated by angioplasty and assessed their impact on the results using a new instrument, the rate of revascularization SYNTAX. Residual baseline SYNTAX score was calculated in 2618 patients registered in the ACUITU study. SYNTAX revascularization index is calculated using the following formula: SYNTAX revascularization index = (1-[residual SYNTAX / basal SYNTAX]) × 100. Results were examined according to 3 groups of revascularization rate SYNTAX: 100% (complete revascularization), 50-99% and <50%. SYNTAX average revascularization rate was 85%, with 1079 patients (41.2%) at 100% rate, 907 patients (34.6%) between 50 and 99% rate and 632 patients (24.1%) at <50% rate. 

At one year, adverse events (including death) were inversely proportional to SINTAX revascularization SYNTAX. In the ROC curves, the cutoff rate of SYNTAX revascularization forecast with the best accuracy for predicting death was <80% (area under the curve of 0.60, IC 95% 0.53 to 0.67, p <0.0001). In the multivariate analysis, the new index was an independent predictor of mortality at one year ([HR] 2.17, IC 95%: 1.05-4.35, p = 0.03) and when compared with other scores it was superior in the ability to predict one-year mortality. 

Conclusion 

SYNTAX revascularization index is a new method to quantify the proportion of coronary heart disease treated with angioplasty. Since their correlation with mortality, the new tool could be useful for measuring the degree of revascularization, being ≥80% index a reasonable target. 

Editorial comment 

The baseline, residual, and SYNTAX index have different meanings and play different roles in daily clinical practice. Baseline score can be used to predict the outcome before revascularization and help decide between angioplasty or surgery, while the residual SYNTAX and SYNTAX index give us prognostic information after the procedure but also assist as a guide about the amount of revascularization or in other words, how much incomplete revascularization we can tolerate. 

All this needs to be validated in other studies that include more patients with multivessel since the average basal SYNTAX of ACUITY study was only 9. Calculating a score prior to the procedure and then again calculating the score and integrate those results in a formula, may be useful in a particular patient, but very challenging in daily practice

SOLACI

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...